API | allogeneic stem cells

allogeneic stem cells Report issue

Cell therapy Experimental

AACT

Active Ingredient History

NOW

Now

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

allogeneic blood stem cell | allogeneic human stem cell | allogeneic peripheral blood stem cells | allogeneic stem cell | allogeneic stem cells | allogenic stem cells

Organizations (93)

Research & Development (93)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (63)

Approved Indications (1)

Guided Tissue Regeneration

Experimental Indications - Clinical Trial Phases 1-4 (62)

Adrenoleukodystrophy (Phase 2)

Allografts (Phase 2)

alpha-Mannosidosis (Phase 2)

Anemia, Sickle Cell (Phase 2)

Aspartylglucosaminuria (Phase 2)

beta-Thalassemia (Phase 2)

Bone Marrow Transplantation (Phase 2)

Dermatitis, Atopic (Phase 1/Phase 2)

Diabetic Foot (Phase 2)

Drugs, Investigational (Phase 2)

Epidermolysis Bullosa Dystrophica (Phase 2)

Fucosidosis (Phase 2)

Graft vs Host Disease (Phase 2/Phase 3)

Granuloma (Early Phase 1)

Granulomatous Disease, Chronic (Early Phase 1)

Hematologic Diseases (Phase 2)

Hematologic Neoplasms (Phase 2)

Hematopoietic Stem Cell Transplantation (Phase 2)

Hemoglobinuria, Paroxysmal (Phase 3)

Histiocytosis (Phase 2)

Hodgkin Disease (Phase 2)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Biphenotypic, Acute (Phase 1/Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid, Acute (Phase 4)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 3)

Leukemia, Prolymphocytic (Phase 1/Phase 2)

Leukemia, Promyelocytic, Acute (Phase 4)

Leukodystrophy, Globoid Cell (Phase 2)

Leukodystrophy, Metachromatic (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 1)

Lymphoma, Follicular (Phase 2/Phase 3)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 3)

Mucopolysaccharidoses (Phase 2)

Mucopolysaccharidosis I (Phase 2)

Mucopolysaccharidosis II (Phase 2)

Mucopolysaccharidosis VI (Phase 2)

Mucopolysaccharidosis VII (Phase 2)

Multiple Myeloma (Phase 3)

Muscular Diseases (Phase 1)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Neuroepithelial (Early Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Pancreatitis (Phase 1/Phase 2)

Peroxisomal Disorders (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Sarcoidosis (Phase 1/Phase 2)

Sarcoma, Ewing (Phase 1)

Scleroderma, Systemic (Phase 1)

Sphingolipidoses (Phase 2)

Stem Cell Transplantation (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 80
# of Trial Organizations: 93

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue